Financials

  • Market Capitalization 259.99 M
  • Employee 533
  • Founded 2002
  • CEO N/A
  • Website www.vandapharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000HT5MG6
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.36
Rapporto prezzo/fatturato
2.41

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3338
EYPT
EyePoint, Inc. - Common Stock
3.07 USD-7.53%-1.29%-28.10%-74.42%264.67 M USD
3351
NAUT
Nautilus Biotechnology, Inc. - Common Stock
2.05 USD-5.53%+22.75%+127.78%+107.07%260.87 M USD
3355
ABEO
Abeona Therapeutics Inc. - Common Stock
4.52 USD-7.76%-8.69%-16.61%-15.51%258.47 M USD
3357
XFOR
X4 Pharmaceuticals, Inc. - Common Stock
2.60 USD-7.80%-5.11%-27.78%-12.46%257.78 M USD

Notizie